Publication Type: Poster
-
Utilizing Serum Proteome to Understand Response and Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
-
The Impact of Blood-Based Host Immune Profiling to Identify Aggressive Early-Stage NSCLC
-
Immunotherapy Alone or with Chemotherapy in Advanced NSCLC? Utility of Clinical Factors and Blood-Based Host Immune Profiling
-
Use of Two Blood-Based Biomarker Tests in Series to Reclassify Risk of Indeterminate Pulmonary Nodules
-
Lung Nodule Integrated Classifier Biomarker: First Data with Real-World Clinical Use
-
Identification of Likely Malignant Indeterminate Pulmonary Nodules by Analysis of Autoantibodies Against Lung Cancer Associated Antigens
-
Real World Data: Importance of Monitoring Blood Based KRAS Mutations and Immune Status in Patients with advanced NSCLC
-
Serum proteomic score for understanding response and mechanism of resistance to immune checkpoint inhibitors in non-small cell lung cancer
-
Serum proteomic score for understanding response and mechanism of immune-related adverse events (irAE) in non-small cell lung cancer
-
Utility of a New Targeted Next Generation Sequencing Test for Liquid Biopsy Samples from Patients with NSCLC